Introduction {#s1}
============

Faithful chromosome segregation during mitotic cell division requires that each pair of sister kinetochores binds to microtubules emanating from opposite spindle poles (bi-orientation). The kinetochore assembles at the centromere of each chromosome to mediate interactions with spindle microtubules ([@bib10]). Kinetochores also recruit proteins to regulate the spindle assembly checkpoint (SAC), a surveillance mechanism that monitors the status of kinetochore--microtubule (KT-MT) attachments and delays anaphase onset until all kinetochores are attached to microtubules ([@bib55]). Kinetochores can be divided into two layers, where the constitutive centromere-associated network (CCAN) resides at the inner kinetochore and the Knl1/Mis12 complex/Ndc80 complex (KMN) network resides at the outer kinetochore ([@bib56]). Within the KMN network, Knl1 is responsible for recruiting proteins that regulate SAC, the Mis12 complex anchors the network to the CCAN, and the Ndc80 complex binds to microtubules ([@bib73]).

Knl1 possesses a large disordered N-terminal region with multiple conserved motifs ([@bib6]). Residing at the far N-terminus is the protein phosphatase 1 (PP1)--binding site, termed SSILK and RVSF motifs ([@bib31]), following which there are multiple MELT motifs that are scattered along the N-terminal half of Knl1. In early mitosis, the SAC kinase Mps1 localizes to unattached kinetochores and phosphorylates the threonine residue in the Knl1-MELT repeats, which in turn recruits the SAC protein Bub3 together with Bub1 and BubR1 (collectively referred to as Bubs) to enable SAC activation ([@bib40]; [@bib51]; [@bib61]; [@bib64]; [@bib75], [@bib74]; [@bib82]; [@bib85]). Meanwhile, Aurora B kinase phosphorylates the serine residue in the Knl1-RVSF motif to inhibit the Knl1--PP1γ interaction ([@bib47]). Upon chromosome alignment on the metaphase spindle, dephosphorylation of the Knl1-RVSF motif results in the recruitment of PP1γ, which in turn dephosphorylates the MELT repeats to release Bubs, eventually leading to SAC silencing and mitotic exit ([@bib23]; [@bib51]; [@bib52]; [@bib58]; [@bib60]; [@bib62]; [@bib72]; [@bib85]).

Hec1 in the Ndc80 complex is important for the binding of kinetochores to microtubules ([@bib54]). In response to lowered tension across kinetochores, Aurora B phosphorylates multiple serine/threonine residues within the N-terminal tail of Hec1 to destabilize microtubules that are improperly attached and to allow another chance for proper attachment to form ([@bib11]; [@bib12], [@bib13]; [@bib18], [@bib19]; [@bib28]; [@bib53]; [@bib79]). This trial-and-error process is pivotal for the correction of aberrant KT-MT attachments ([@bib30]; [@bib42]). When chromosomes are aligned at the metaphase plate, these Aurora B target sites are dephosphorylated, resulting in stabilization of microtubule attachments. Thus, through phosphorylating the Knl1-RVSF motif and the N-terminal segment of Hec1, Aurora B plays an essential role in chromosome bi-orientation.

Aurora B is the enzymatic component of the chromosomal passenger complex (CPC), which also includes the regulatory subunits Survivin, Borealin, and inner centromere protein (INCENP; [@bib9]). During prophase through metaphase, CPC predominantly localizes to the inner centromere, a specialized chromatin region that lies at the intersection of the interkinetochore axis and inter--sister chromatin axis. Localization of Aurora B at the inner centromere is central to the prevailing tension-based spatial separation model for how Aurora B senses and corrects erroneous KT-MT attachments ([@bib41]; [@bib46]; [@bib66]). However, this view has been challenged by several surprising observations that inner-centromeric localization of Aurora B is dispensable for chromosome bi-orientation in budding yeast ([@bib8]), chicken cells ([@bib84]), and human cells ([@bib32]). Whether and how centromere-localized Aurora B regulates chromosome bi-orientation and segregation remains a major outstanding question ([@bib4]; [@bib8]; [@bib17]; [@bib33]; [@bib38]; [@bib39]; [@bib41]; [@bib43]; [@bib46]; [@bib78]; [@bib79]; [@bib83]; [@bib84]).

An intricate and evolutionarily conserved signaling network involving Haspin-mediated histone H3 Thr-3 phosphorylation (H3pT3) and Bub1-mediated histone H2A Thr-120 phosphorylation (H2ApT120) underlies the defined localization of Aurora B at the inner centromere. H3pT3 is concentrated at the inner centromere ([@bib15], [@bib16]) and is directly recognized by Survivin ([@bib37]; [@bib77]; [@bib81]). H2ApT120 is enriched at the KT-proximal centromere and is directly recognized by Sgo1 ([@bib36]; [@bib49]), which in turn recruits Cdk1-phosphorylated Borealin ([@bib70]). It has been proposed that CPC localization at centromeres requires the combination of these two histone marks ([@bib81]). However, the underlying molecular mechanism remains elusive ([@bib39]; [@bib69]; [@bib33]). Here we show how these two phospho-histone marks collaborate to control the localization and activity of Aurora B at centromeres to ensure the fidelity of chromosome segregation during mitosis.

Results {#s2}
=======

Either H3pT3 or H2ApT120 alone is sufficient to recruit Aurora B {#s3}
----------------------------------------------------------------

To investigate how H3pT3 and H2ApT120 localize the CPC to inner centromeres, we first tested whether these two histone marks could recruit CPC independently, using a U2OS-derived cell line in which multiple copies of Lac Operator (LacO) repeats were stably integrated in an euchromatic region of chromosome 1 ([@bib34]). As expected, tethering EGFP-fused Lac repressor (EGFP-LacI) alone to the LacO array did not generate H3pT3 or H2ApT120 ([Fig. 1, A--C](#fig1){ref-type="fig"}). While tethering Haspin kinase domain as a fusion protein with EGFP-LacI (EGFP-LacI-Haspin-K) to the LacO array generated H3pT3 but not H2ApT120, tethering EGFP-LacI--fused Bub1 kinase domain (EGFP-LacI-Bub1-K) generated H2ApT120 but not H3pT3 in interphase cells. By contrast, the kinase-dead mutant forms of Haspin (K511A) and Bub1 (D946N) were unable to do so. Importantly, expression of EGFP-LacI-Haspin, but not EGFP-LacI or EGFP-LacI-Haspin-K511A, generated H3pT3 and recruited Aurora B ([Fig. 1, D and E](#fig1){ref-type="fig"}). Thus, H3pT3, presumably through binding Survivin, can recruit Aurora B to an ectopic chromatin locus in the absence of H2ApT120.

![**Either H3pT3 or H2ApT120 alone is sufficient to recruit Aurora B.** **(A--C)** U2OS-LacO cells expressing EGFP-LacI, EGFP-LacI-Haspin-K, or EGFP-LacI-Bub1-K (WT or kinase-dead) were fixed and then subjected to immunofluorescence staining with DAPI and antibodies for H3pT3 and H2ApT120. Example images are shown (A). The relative enrichment of H3pT3 (B) and H2ApT120 (C) at the LacO repeats was quantified in 50 cells. **(D and E)** U2OS-LacO cells expressing WT or the kinase-dead mutant of EGFP-LacI-Haspin were fixed for immunostaining. Example images are shown (D). The relative enrichment of Aurora B at the LacO repeats was quantified in 50 cells (E). **(F and G)** U2OS-LacO cells expressing EGFP-LacI or EGFP-LacI-Bub1-K (WT or kinase-dead) were fixed for immunostaining. Example images are shown (F). The relative enrichment of Sgo1 at the LacO repeats was quantified in 50 cells (G). **(H)** U2OS-LacO cells expressing EGFP-LacI-Bub1-K (WT or kinase-dead) were exposed to nocodazole for 3 h. Mitotic cells were cytospun onto coverslips, fixed, and subjected to immunofluorescence staining with DAPI, ACA, and the antibody for Aurora B. Example images are shown. **(I)** U2OS-LacO cells expressing the indicated EGFP-LacI fusion proteins were exposed to nocodazole and 5-ITu for 3 h. Mitotic cells were cytospun onto coverslips and fixed for immunostaining as in H. **(J)** U2OS-LacO cells expressing the indicated EGFP-LacI fusion proteins and transfected with control siRNA or Sgo1 siRNA were exposed to nocodazole for 3 h. Mitotic cells were cytospun onto coverslips and fixed for immunostaining as in H. Means and SDs are shown (B, C, E, and G; unpaired *t* test). Arrows point to the LacO array. Scale bars, 10 µm.](JCB_201907092_Fig1){#fig1}

Moreover, when tethered to the LacO array, EGFP-LacI-Bub1-K but not EGFP-LacI-Bub1-K-D946N generated H2ApT120 and recruited Sgo1 in interphase cells ([Fig. 1, F and G](#fig1){ref-type="fig"}). Importantly, EGFP-LacI-Bub1-K, but not EGFP-LacI-Bub1-K-D946N, recruited Aurora B to the LacO array on the chromosome in cells that were arrested in mitosis by the microtubule destabilizer nocodazole ([Fig. 1 H](#fig1){ref-type="fig"}). Similar results were observed when EGFP-LacI-Bub1-K--expressing cells were treated with 5-iodotubercidin (5-ITu; [Fig. 1 I](#fig1){ref-type="fig"}), a potent and selective small-molecule inhibitor of Haspin ([@bib17]; [@bib78]). Furthermore, expression of EGFP-LacI-Bub1-K could not recruit Aurora B to the LacO array when endogenous Sgo1 was depleted by siRNA ([Fig. 1 J](#fig1){ref-type="fig"}). Thus, H2ApT120 is sufficient to recruit Aurora B in mitotic cells lacking H3pT3, likely through the binding of Sgo1 to Borealin.

Taken together, our observation that either H3pT3 or H2ApT120 is sufficient to recruit Aurora B suggests that the CPC may not need to bind H3pT3 and H2ApT120 simultaneously to localize to centromeres.

Disrupting the H3pT3--Survivin interaction increases H2ApT120 and Sgo1 at metaphase centromeres {#s4}
-----------------------------------------------------------------------------------------------

Structural analysis revealed that the BIR domain of Survivin binds H3pT3 through side chains of Lys-62 and His-80 that are hydrogen bonded with the phosphate, and that the ring nitrogen of His-80 forms a hydrogen bond with the carbonyl group of Ala-1 of H3 ([@bib21]; [@bib35]; [@bib57]). Therefore, these two residues (K62 and H80) are crucial for the phospho-specific binding of Survivin to H3. When endogenous Survivin was stably depleted by CRISPR/Cas9-mediated genome editing, the stably expressed Survivin mutants with Myc-tag (Survivin-K62A-Myc and Survivin-H80A-Myc) are largely impaired in supporting Aurora B localization at centromeres ([@bib44]).

Fluorescence microscopy showed that H2ApT120 was highly enriched at prometaphase centromeres and was then largely reduced at metaphase centromeres in control cells exogenously expressing WT Survivin (Survivin-WT-Myc; [Fig. 2, A--C](#fig2){ref-type="fig"}), which is expected ([@bib36]). Moreover, the level of H2ApT120 at prometaphase kinetochores was comparable in control cells and cells expressing Survivin-K62A-Myc or Survivin-H80A-Myc. Strikingly, H2ApT120 at metaphase kinetochores was clearly lower in control cells than in Survivin mutant cells, indicating that the normal decline in H2ApT120 at metaphase centromeres is impeded in the absence of H3pT3--Survivin interaction. Consistent with the role of H2ApT120 in recruiting Sgo1 to centromeres, loss of the H3pT3--Survivin interaction caused an increase in the centromeric localization of Sgo1 during metaphase but not prometaphase ([Fig. 2, A, D, and E](#fig2){ref-type="fig"}). Similar results were observed when HeLa cells were treated with 5-ITu ([Fig. 2, F--J](#fig2){ref-type="fig"}). Together, these results indicate that, through binding Survivin, H3pT3 promotes the timely dephosphorylation of H2ApT120 and release of Sgo1 at metaphase centromeres.

![**Disrupting the H3pT3--Survivin interaction increases H2ApT120 and Sgo1 at metaphase centromeres.** **(A--E)** HeLa cells stably expressing the indicated Survivin proteins were released from STB for 12 h and then immunostained. Example images are shown (A). For each experiment, the immunofluorescence intensity ratios of H2ApT120/ACA (B) and Sgo1/ACA (D) were determined from 200 chromosomal regions containing \>600 centromeres in 20 cells. The relative intensities of H2ApT120 (C) and Sgo1 (E), representing the normalized ratios of H2ApT120/ACA and Sgo1/ACA, were determined in 60 cells from three independent experiments (20 cells per experiment). **(F--J)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (F). For each experiment, the immunofluorescence intensity ratios of H2ApT120/ACA (G) and Sgo1/ACA (I) were determined from 200 chromosomal regions containing \>600 centromeres in 20 cells. The relative intensities of H2ApT120 (H) and Sgo1 (J), representing the normalized ratios of H2ApT120/ACA and Sgo1/ACA, were determined in 60 cells from three independent experiments (20 cells per experiment). Means and SDs are shown (B--E and G--J; unpaired *t* test). N.S., not significant. Scale bars, 10 µm.](JCB_201907092_Fig2){#fig2}

Disrupting the H3pT3--Survivin interaction reveals an H2ApT120-dependent pool of Aurora B at the KT-proximal centromere {#s5}
-----------------------------------------------------------------------------------------------------------------------

Given the capability of H2ApT120 in binding Sgo1 and recruiting the CPC, we were prompted to analyze the precise localization of Aurora B on chromosome spreads prepared from cells briefly arrested in metaphase with the proteasome inhibitor MG132. As in control HeLa cells, Aurora B was highly enriched at the inner centromere in cells expressing Survivin-WT-Myc and was mainly observed as a single focus between the sister CENP-C dot pair, a component protein of the CCAN at the inner kinetochore ([Fig. 3 A](#fig3){ref-type="fig"}). Strikingly, in cells expressing Survivin-K62A-Myc or Survivin-H80A-Myc, Aurora B tended to appear as two relatively weak foci at the outer edge of centromere proximal to CENP-C. This pool of Aurora B at the KT-proximal centromere was also observed when Haspin-mediated H3pT3 was inhibited by 5-ITu in MG132-arrested metaphase HeLa cells ([Fig. 3 B](#fig3){ref-type="fig"}) and nocodazole-arrested mitotic HeLa cells ([Fig. 3 C](#fig3){ref-type="fig"}).

![**Disrupting the H3pT3--Survivin interaction reveals an H2ApT120-dependent pool of Aurora B at the KT-proximal centromere.** **(A)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB, and then MG132 was added 10 h after release. Chromosome spreads were prepared from mitotic cells collected 15 h after release and then immunostained. **(B)** DMSO or the indicated inhibitors was added to HeLa cells 7 h after release from STB, and MG132 was added 10 h after release. Chromosome spreads were prepared and immunostained as described in A. **(C)** Nocodazole and DMSO or the indicated inhibitors were added to HeLa cells 9 h after release from STB. Chromosome spreads were prepared from mitotic cells collected 12 h after release and then immunostained. Line plots and scatter plots show the fluorescence intensity across a sister kinetochore pair for Aurora B and the inner kinetochore marker CENP-C on 1 chromosome and 10 chromosomes, respectively. **(D)** Nocodazole and DMSO or the indicated inhibitors were added to HeLa cells 9 h after release from STB. Chromosome spreads were prepared and immunostained as described in C. Line plots and scatter plots show the fluorescence intensity across a sister kinetochore pair for Aurora B and H2ApT120 on 1 chromosome and 10 chromosomes, respectively. Scale bars, 10 µm.](JCB_201907092_Fig3){#fig3}

We further found that Aurora B frequently colocalized with H2ApT120 at the KT-proximal centromere in nocodazole-arrested mitotic HeLa cells treated with 5-ITu ([Fig. 3 D](#fig3){ref-type="fig"}), implying that H2ApT120 may be involved in localizing Aurora B to the KT-proximal centromere. Indeed, when H2ApT120 was abolished by treatment with BAY 1816032, a recently developed small-molecular inhibitor of Bub1 kinase ([@bib65]), Aurora B was no longer enriched at centromeres in Survivin mutant cells and 5-ITu-treated HeLa cells ([Fig. 3, A--D](#fig3){ref-type="fig"}). Thus, disrupting the H3pT3--Survivin interaction reveals a pool of Aurora B that is present at the KT-proximal centromere, presumably through interacting with H2ApT120-bound Sgo1.

Disrupting the H3pT3--Survivin interaction delays metaphase--anaphase transition in a Bub1-dependent way {#s6}
--------------------------------------------------------------------------------------------------------

We next determined the impact of loss of the H3pT3--Survivin interaction on mitosis progression. To allow live imaging by fluorescence microscopy, we stably expressed histone H2B C-terminally fused to GFP (H2B-GFP) in cells expressing Survivin-WT-Myc or the K62A and H80A mutants ([Fig. S1 A](#figS1){ref-type="fig"}). Time-lapse live imaging showed that the time required for the transition from nuclear envelope breakdown (NEB) to the accomplishment of metaphase chromosome alignment was comparable in Survivin-WT-Myc cells and mutant cells ([Fig. 4, A and B](#fig4){ref-type="fig"}; [Fig. S1, B and C](#figS1){ref-type="fig"}; and [Videos 1](#video1){ref-type="fig"}, [2](#video2){ref-type="fig"}, and [3](#video3){ref-type="fig"}). In contrast, compared with that in cells expressing Survivin-WT-Myc, the time required for the transition from the completion of metaphase chromosome alignment to anaphase onset was significantly increased in Survivin mutant cells. We observed a similar delay in the metaphase--anaphase transition, but not the NEB--metaphase transition, when HeLa cells stably expressing H2B-GFP were treated with 5-ITu ([Fig. 4 C](#fig4){ref-type="fig"}; [Fig. S1, D and E](#figS1){ref-type="fig"}; and [Videos 4](#video4){ref-type="fig"}, [5](#video5){ref-type="fig"}, and [6](#video6){ref-type="fig"}). Moreover, when cells were released from transient metaphase arrest induced by MG132 treatment, there was a dose-dependent delay in the onset of anaphase chromosome segregation in the presence of 5-ITu ([Fig. 4, D and E](#fig4){ref-type="fig"}; and [Videos 7](#video7){ref-type="fig"} and [8](#video8){ref-type="fig"}). In addition, 5-ITu treatment delayed the metaphase--anaphase transition in cells expressing Survivin-WT-Myc but not Survivin-H80A-Myc ([Fig. S1, F and G](#figS1){ref-type="fig"}), validating the specificity of the phenotype.

![**Disrupting the H3pT3--Survivin interaction delays metaphase--anaphase transition in a Bub1-dependent way.** **(A and B)** HeLa and the indicated Survivin cell lines stably expressing H2B-GFP were released from STB, and then mitosis progression was analyzed by time-lapse live imaging. The time from NEB to metaphase chromosome alignment and from metaphase to anaphase onset was determined in ≥66 cells (A). Selected frames of the videos are shown (B). See also [Videos 1](#video1){ref-type="fig"}, [2](#video2){ref-type="fig"}, and [3](#video3){ref-type="fig"}. **(C)** DMSO or 0.3--0.6 µM 5-ITu was added to HeLa cells stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed in ≥64 cells. See also [Videos 4](#video4){ref-type="fig"}, [5](#video5){ref-type="fig"}, and [6](#video6){ref-type="fig"}. **(D and E)** MG132 was added to HeLa cells stably expressing H2B-GFP 10.5 h after release from STB. After 2-h incubation in MG132, cells were released into DMSO or 0.3--1.0 µM 5-ITu, and then mitosis progression was analyzed by time-lapse live imaging. The time from MG132 release to anaphase onset was determined in ≥200 cells (D). Selected frames of the videos are shown (E). See also [Videos 7](#video7){ref-type="fig"} and [8](#video8){ref-type="fig"}. **(F and G)** DMSO or BAY 1816032 was added to the indicated Survivin cell lines stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed in ≥66 cells (F). Selected frames of the videos are shown (G). **(H and I)** DMSO or the indicated inhibitors was added to HeLa cells stably expressing H2B-GFP at 7 h after release from STB, and then mitosis progression was analyzed in ≥45 cells (H). Selected frames of the videos are shown (I). Means and SDs are shown (A, C, D, F, and H; unpaired *t* test). N.S., not significant. Time stated in h:min. Scale bars, 10 μm. See also [Fig. S1](#figS1){ref-type="fig"}.](JCB_201907092_Fig4){#fig4}

![**Disrupting the H3pT3--Survivin interaction delays metaphase--anaphase transition in a Bub1-dependent way.** Related to [Fig. 4](#fig4){ref-type="fig"}. **(A)** HeLa and the indicated Survivin cell lines stably expressing H2B-GFP were treated with nocodazole for 14 h, and then mitotic cells were collected. The samples were analyzed by immunoblotting. Ex., exogenous Survivin; En., endogenous Survivin. **(B)** Survivin-WT-Myc and Survivin-K62A-Myc cell lines stably expressing H2B-GFP were released from STB, and then mitosis progression was analyzed by time-lapse live imaging as described in [Fig. 4 A](#fig4){ref-type="fig"}. Mitotic duration was determined in \>198 cells for each condition from three independent experiments. **(C)** HeLa and the indicated Survivin cell lines stably expressing H2B-GFP were released from STB, and then mitosis progression was analyzed by time-lapse live imaging as in [Fig. 4 A](#fig4){ref-type="fig"}. The mitotic duration was determined in \>200 cells for each condition from three independent experiments. **(D and E)** DMSO or 5-ITu was added to HeLa cells stably expressing H2B-GFP released from STB, and then mitosis progression was analyzed as described in [Fig. 4 C](#fig4){ref-type="fig"}. Selected frames of the videos are shown (D). The mitotic duration was determined in \>250 cells for each condition from four independent experiments (E). **(F and G)** DMSO or 5-ITu was added to the indicated Survivin cell lines stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed by time-lapse live imaging. The time from NEB to metaphase chromosome alignment and from metaphase to anaphase onset was determined in ≥60 cells (F). Selected frames of the videos are shown (G). **(H and I)** DMSO or 4 µM BAY 1816032 was added to HeLa cells stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed by time-lapse live imaging. The time from NEB to metaphase chromosome alignment and from metaphase to anaphase onset was determined in ≥69 cells (H). Selected frames of the videos are shown (I). See also [Videos 9](#video9){ref-type="fig"} and [10](#video10){ref-type="fig"}. **(J)** DMSO or 3 µM BAY 1816032 was added to HeLa cells stably expressing H2B-GFP released from STB, and then mitosis progression was analyzed as in H. The means and ranges of mitotic duration were determined in \>100 cells for each condition from two independent experiments. **(K)** DMSO or 3 µM BAY 1816032 was added to the indicated Survivin cell lines stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed as in [Fig. 4 F](#fig4){ref-type="fig"}. The mitotic duration was determined in \>144 cells for each condition from three independent experiments. **(L)** DMSO or the indicated inhibitors were added to HeLa cells stably expressing H2B-GFP 7 h after release from STB, and then mitosis progression was analyzed as in [Fig. 4 H](#fig4){ref-type="fig"}. The means and ranges of mitotic duration were determined in \>90 cells for each condition from two independent experiments. Means and SDs are shown (B, C, E, F, H, K, and L; unpaired *t* test). N.S., not significant. Time stated in h:min. Scale bars, 10 µm.](JCB_201907092_FigS1){#figS1}
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**Time-lapse epifluorescence microscopy of mitosis progression in HeLa cells expressing Survivin-WT-Myc and H2B-GFP.** Related to [Fig. 4 A](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in HeLa cells expressing Survivin-K62A-Myc and H2B-GFP.** Related to [Fig. 4 A](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in HeLa cells expressing Survivin-H80A-Myc and H2B-GFP.** Related to [Fig. 4 A](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP-expressing HeLa cells treated with DMSO.** Related to [Fig. 4 C](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP-expressing HeLa cells treated with 0.3 µM 5-ITu.** Related to [Fig. 4 C](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP-expressing HeLa cells treated with 0.6 µM 5-ITu.** Related to [Fig. 4 C](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP-expressing HeLa cells released from MG132 into DMSO.** Related to [Fig. 4 D](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP-expressing HeLa cells released from MG132 into 0.6 µM 5-ITu.** Related to [Fig. 4 D](#fig4){ref-type="fig"}. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.

We further examined the effect of BAY 1816032 on mitosis progression. Treatment of HeLa cells with BAY 1816032 increased the time required for metaphase chromosome alignment but not the metaphase--anaphase transition ([Fig. S1, H--J](#figS1){ref-type="fig"}; and [Videos 9](#video9){ref-type="fig"} and [10](#video10){ref-type="fig"}), which is in line with a role for Bub1 kinase activity in promoting the efficiency of chromosome alignment ([@bib3]). Interestingly, though BAY 1816032 caused a delay in the NEB--metaphase transition, it restored the proper timing for metaphase--anaphase transition in cells expressing Survivin-H80A-Myc ([Fig. 4, F and G](#fig4){ref-type="fig"}; and [Fig. S1 K](#figS1){ref-type="fig"}). Similarly, simultaneous treatment of HeLa cells with 5-ITu and BAY 1816032 caused a delay in NEB--metaphase transition but not in the metaphase--anaphase transition ([Fig. 4, H and I](#fig4){ref-type="fig"}; and [Fig. S1 L](#figS1){ref-type="fig"}).

Therefore, loss of H3pT3--Survivin interaction delays metaphase--anaphase transition in a Bub1-dependent manner, raising the possibility that H2ApT120-dependent localization of Aurora B at the KT-proximal centromere influences silencing of the SAC.

Disrupting the H3pT3--Survivin interaction hampers the removal of SAC proteins from metaphase kinetochores {#s7}
----------------------------------------------------------------------------------------------------------

Bubs are largely released from kinetochores to allow SAC silencing ([@bib50]). We therefore investigated the kinetochore localization of Bubs in cells lacking the H3pT3--Survivin interaction. As expected, Bub1 ([Fig. 5, A and B](#fig5){ref-type="fig"}) and Bub3 ([Fig. S2, A and B](#figS2){ref-type="fig"}) localized to prometaphase kinetochores and were largely released from metaphase kinetochores in Survivin-WT-Myc cells. The levels of Bubs at prometaphase kinetochores in Survivin mutant cells were comparable to those in Survivin-WT-Myc cells, indicating that SAC activation is normal in the absence of H3pT3--Survivin interaction. Interestingly, at metaphase kinetochores, the levels of Bub1 and Bub3 were higher in Survivin mutant cells than in Survivin-WT-Myc cells. These results are in line with the increased H2ApT120 in metaphase cells lacking the H3pT3--Survivin interaction ([Fig. 2, A--C and F--H](#fig2){ref-type="fig"}). Similarly, treatment of HeLa cells with 5-ITu increased the kinetochore localization of Bub3 ([Fig. 5, C and D](#fig5){ref-type="fig"}) and BubR1 ([Fig. S2, C and D](#figS2){ref-type="fig"}) during metaphase but not prometaphase. In addition, 5-ITu was able to increase the metaphase kinetochore localization of Bubs in Survivin-WT-Myc cells but not in the Survivin mutant cells ([Fig. S2, E--H](#figS2){ref-type="fig"}). Furthermore, treatment with BAY 1816032 eliminated the localization of Bub3 and Bub1 at metaphase kinetochores in cells expressing either WT or the mutant forms of Survivin-Myc ([Fig. 5, E--G](#fig5){ref-type="fig"}) but did not affect their localization at prometaphase kinetochores ([Fig. 5, H--J](#fig5){ref-type="fig"}).

![**Disrupting the H3pT3--Survivin interaction hampers the removal of SAC proteins from metaphase kinetochores.** **(A and B)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (A). The relative intensity of Bub1, representing the normalized ratio of Bub1/ACA, was determined in 60 cells from three independent experiments (20 cells per experiment; B). **(C and D)** DMSO or 5-ITu was added to HeLa cells 7 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The relative intensity of Bub3 was determined as in B (D). **(E--G)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (E). The relative intensity ratios of Bub3 (F) and Bub1 (G) were determined as in B. **(H--J)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (H). The relative intensity ratios of Bub3 (I) and Bub1 (J) were determined as in B. Means and SDs are shown (B, D, F, G, I, and J; unpaired *t* test). N.S., not significant. Scale bars, 10 µm. See also [Fig. S2](#figS2){ref-type="fig"}.](JCB_201907092_Fig5){#fig5}

![**Disrupting the H3pT3--Survivin interaction hampers the removal of SAC proteins from metaphase kinetochores.** Related to [Fig. 5](#fig5){ref-type="fig"}. **(A and B)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (A). The immunofluorescence intensity ratio of Bub3/ACA was determined from 200 chromosomal regions containing \>600 centromeres in 20 cells (B). **(C and D)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The immunofluorescence intensity ratio of BubR1/ACA was determined from 200 chromosomal regions containing \>600 centromeres in 20 cells (D). **(E--H)** DMSO or 5-ITu was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (E and G). The immunofluorescence intensity ratios of Bub3/ACA (F) and Bub1/ACA (H) were determined from 200 chromosomal regions containing \>600 centromeres in 20 cells. Means and SDs are shown (B, D, F, and H; unpaired *t* test). N.S., not significant. Scale bars, 10 µm.](JCB_201907092_FigS2){#figS2}

Thus, release of Bubs from metaphase kinetochores in cells lacking the H3pT3--Survivin interaction is hampered in a Bub1 kinase activity--dependent manner, which may account for the prolonged metaphase in these cells and suggest a delay in SAC silencing.

Disrupting the H3pT3--Survivin interaction hinders dephosphorylation of Knl1-MELT motifs at metaphase kinetochores in a Bub1-dependent way {#s8}
------------------------------------------------------------------------------------------------------------------------------------------

While Mps1-mediated phosphorylation of Knl1-MELT motifs recruits Bubs to kinetochores during prometaphase, dephosphorylation of Knl1-MELT at metaphase kinetochores causes the release of Bubs ([@bib55]). The delay in releasing Bubs from metaphase kinetochores in cells lacking H3pT3--Survivin interaction prompted us to examine the level of Knl1-MELT phosphorylation (Knl1-pMELT) therein, using the antibody specific for phosphorylated Thr-180 in one of the MELT repeats of human Knl1 ([@bib59]).

We found that Knl1 localized normally to kinetochores in cells expressing WT or the mutant forms of Survivin-Myc ([Fig. S3, A and B](#figS3){ref-type="fig"}), as well as in cells treated with 5-ITu ([Fig. S3, C and D](#figS3){ref-type="fig"}), indicating that the H3pT3--Survivin interaction is dispensable for outer kinetochore assembly. Strikingly, compared with that in control cells, Knl1-pMELT at metaphase kinetochores was clearly elevated in cells expressing the Survivin mutants ([Fig. 6, A and B](#fig6){ref-type="fig"}) or treated with 5-ITu ([Fig. 6, C and D](#fig6){ref-type="fig"}). In addition, 5-ITu treatment increased Knl1-pMELT at metaphase kinetochores in cells expressing Survivin-WT-Myc but not Survivin-H80A-Myc ([Fig. S3, E and F](#figS3){ref-type="fig"}). Furthermore, treatment with BAY 1816032 largely eliminated Knl1-pMELT at metaphase kinetochores in cells expressing Survivin-WT-Myc or the mutants, whereas little effect was observed on Knl1-pMELT at prometaphase kinetochores ([Fig. 6, E--G](#fig6){ref-type="fig"}). Thus, retention of both Knl1-pMELT and Bubs at metaphase kinetochores in cells lacking the H3pT3--Survivin interaction requires Bub1 kinase activity.

![**Disrupting the H3pT3--Survivin interaction hinders dephosphorylation of Knl1-MELT motifs at metaphase kinetochores in a Bub1-dependent way.** **(A and B)** The indicated Survivin stable cell lines were released from STB for 12 h, and then immunostained. Example images are shown (A). The relative intensity of Knl1-pMELT, representing the normalized ratio of Knl1-pMELT/ACA, was determined in 60 cells from three independent experiments (20 cells per experiment; B). **(C and D)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The relative intensity of Knl1-pMELT/ACA was determined as in B (D). **(E--G)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (E). The relative intensity of Knl1-pMELT/ACA in prometaphase (F) and metaphase (G) cells were determined as in B. Means and SDs are shown (B, D, F, and G; unpaired *t* test). N.S., not significant. Scale bars, 10 µm. See also [Fig. S3](#figS3){ref-type="fig"}.](JCB_201907092_Fig6){#fig6}

![**Disrupting the H3pT3--Survivin interaction hinders dephosphorylation of Knl1-MELT motifs at metaphase kinetochores in a Bub1-dependent way.** Related to [Fig. 6](#fig6){ref-type="fig"}. **(A and B)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (A). The relative intensity of Knl1, representing the normalized ratio of Knl1/ACA, was determined from 300 chromosomal regions containing \>900 centromeres in 30 cells (B). **(C and D)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The relative intensity of Knl1, representing the normalized ratio of Knl1/ACA, were determined from 300 chromosomal regions containing \>900 centromeres in 30 cells (D). **(E and F)** DMSO or 5-ITu was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (E). The immunofluorescence intensity ratio of Knl1-pMELT/ACA was determined from 200 chromosomal regions containing \>600 centromeres in 20 cells (F). Means and SDs are shown (B, D, and F; unpaired *t* test). N.S., not significant. Scale bars, 10 µm.](JCB_201907092_FigS3){#figS3}

These results indicate that dephosphorylation of Knl1-MELT during metaphase is hindered when the H3pT3--Survivin interaction is lost, which is expected to interfere with the release of Bubs from metaphase kinetochores and might contribute to a defect in SAC silencing.

Disrupting the H3pT3--Survivin interaction impedes the dephosphorylation of Knl1-RVSF motif at metaphase kinetochores in a Bub1-dependent manner {#s9}
------------------------------------------------------------------------------------------------------------------------------------------------

Dephosphorylation of Knl1-MELT in metaphase depends on PP1γ ([@bib58]), which is recruited to metaphase kinetochores through binding Knl1, whereas the Knl1--PP1γ interaction is inhibited by Aurora B--mediated phosphorylation of Knl1 at the RVSF motif (Knl1-pRVSF). We examined whether loss of H3pT3--Survivin interaction affects Knl1-pRVSF, using the antibody specific for phosphorylated Ser-60 in the RVSF motif of human Knl1 ([@bib79]).

We found comparable levels of Knl1-pRVSF at prometaphase kinetochores in cells expressing Survivin-WT-Myc and the mutants ([Fig. 7, A and B](#fig7){ref-type="fig"}). Moreover, compared with that at prometaphase kinetochores, Knl1-pRVSF at metaphase kinetochores was strongly reduced in cells expressing Survivin-WT-Myc, which is expected ([@bib79]). Strikingly, Knl1-pRVSF at metaphase kinetochores was largely retained in cells expressing the Survivin mutants. Similarly, treatment of HeLa cells with 5-ITu did not affect Knl1-pRVSF at prometaphase kinetochores, but significantly increased Knl1-pRVSF at metaphase kinetochores ([Fig. 7, C and D](#fig7){ref-type="fig"}). 5-ITu increased Knl1-pRVSF at metaphase kinetochores in cells expressing Survivin-WT-Myc but not Survivin-H80A-Myc ([Fig. S4, A and B](#figS4){ref-type="fig"}), validating the specificity of the effect. Furthermore, BAY 1816032 did not affect Knl1-pRVSF at prometaphase kinetochores in cells expressing Survivin-WT-Myc or the mutants ([Fig. 7, E and F](#fig7){ref-type="fig"}). In contrast, BAY 1816032 treatment prevented the increase in Knl1-pRVSF at metaphase kinetochores in Survivin mutant cells ([Fig. 7, E and G](#fig7){ref-type="fig"}). We observed similar results for the phosphorylation of Knl1-SSILK motif (Knl1-pSSILK; [Fig. S4, C--E](#figS4){ref-type="fig"}), using the antibody for phosphorylated Ser-24 in the SSILK motif of human Knl1 ([@bib79]), indicating that the phenotype is not specific for Knl1-pRVSF.

![**Disrupting the H3pT3--Survivin interaction impedes the dephosphorylation of Knl1-RVSF motif at metaphase kinetochores in a Bub1-dependent manner.** **(A and B)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (A). The relative intensity of Knl1-pRVSF, representing the normalized ratio of Knl1-pRVSF/ACA, was determined in 60 cells from three independent experiments (20 cells per experiment; B). **(C and D)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The relative intensity of Knl1-pRVSF/ACA was determined as in B (D). **(E--G)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (E). The relative intensity ratio of Knl1-pRVSF/ACA in prometaphase (F) and metaphase (G) cells was determined as in B. Means and SDs are shown (B, D, F, and G; unpaired *t* test). N.S., not significant. Scale bars, 10 µm. See also [Fig. S4](#figS4){ref-type="fig"}.](JCB_201907092_Fig7){#fig7}

![**Disrupting the H3pT3--Survivin interaction impedes the dephosphorylation of Knl1-RVSF motif at metaphase kinetochores in a Bub1-dependent manner.** Related to [Fig. 7](#fig7){ref-type="fig"}. **(A and B)** DMSO or 5-ITu was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (A). The immunofluorescence intensity ratio of Knl1-pRVSF/ACA was determined from 200 chromosomal regions containing \>600 centromeres in 20 cells (B). **(C--E)** DMSO or BAY 1816032 was added to the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The immunofluorescence intensity ratio of Knl1-pS24/ACA in prometaphase (D) and metaphase (E) was determined from 200 chromosomal regions containing \>600 centromeres in 20 cells. Means and SDs are shown (B, D, and E; unpaired *t* test). N.S., not significant. Scale bars, 10 µm.](JCB_201907092_FigS4){#figS4}

Thus, loss of H3pT3--Survivin interaction impedes the dephosphorylation of Knl1-RVSF at metaphase kinetochores in a way dependent on Bub1 kinase activity, which is likely the cause for the delay in dephosphorylating Knl1-MELT during metaphase.

Disrupting the H3pT3--Survivin interaction does not delay metaphase Knl1 dephosphorylation and SAC silencing in cells lacking H2ApT120-bound Sgo1 {#s10}
-------------------------------------------------------------------------------------------------------------------------------------------------

The above results suggest that H2ApT120-dependent accumulation of Aurora B at the KT-proximal centromere might be responsible for retaining Knl1-pRVSF at metaphase kinetochores in cells lacking the H3pT3--Survivin interaction. In line with the role for H2ApT120-bound Sgo1 in recruiting the CPC ([@bib70]), Sgo1 tethered to the LacO array as a fusion protein with Myc-tagged LacI (Sgo1-Myc-LacI) recruited INCENP to the LacO array on the mitotic chromosome in U2OS-LacO cells ([Fig. S5 A](#figS5){ref-type="fig"}). Similar results were observed in 5-ITu--treated mitotic U2OS-LacO cells expressing EGFP-LacI--fused Sgo1 (EGFP-LacI-Sgo1; [Fig. S5 B](#figS5){ref-type="fig"}).

![**Disrupting the H3pT3--Survivin interaction does not delay metaphase Knl1 dephosphorylation and SAC silencing in cells lacking H2ApT120-bound Sgo1.** Related to [Fig. 8](#fig8){ref-type="fig"}. **(A)** U2OS-LacO cells expressing Sgo1-Myc-LacI were exposed to nocodazole for 3 h. Mitotic cells were cytospun onto coverslips, fixed, and subjected to immunofluorescence staining with DAPI and antibodies for Myc, INCENP, and CENP-C. Example images are shown. **(B)** U2OS-LacO cells expressing the indicated EGFP-LacI-Sgo1 were exposed to nocodazole and 5-ITu for 3 h. Mitotic cells were cytospun onto coverslips, fixed, and subjected to immunofluorescence staining with DAPI, ACA, and the antibody for Aurora B. Example images are shown. **(C--G)**DMSO or 5-ITu was added to HeLa or the Sgo1-K492A cells at 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (C). The immunofluorescence intensity ratios of Bub1/ACA in prometaphase (D) and metaphase (E) and Bub3/ACA in prometaphase (F) and metaphase (G) were determined from 200 chromosomal regions containing \>600 centromeres in 20 cells. Means and SDs are shown (D--G; unpaired *t* test). N.S., not significant. Arrows point to the LacO array. Scale bars, 10 µm.](JCB_201907092_FigS5){#figS5}

We thus wondered whether disrupting the H3pT3--Survivin interaction could impede the dephosphorylation of Knl1-RVSF at metaphase kinetochores in cells where Sgo1 is incapable of binding H2ApT120. To test this possibility, we used a previously established HeLa-derived cell line in which the Lys-492 to Ala (K492A) mutation in the C-terminal basic region of Sgo1, which renders Sgo1 deficient in binding H2ApT120 and localizing to centromeres ([@bib48]; [@bib67]), was introduced into endogenous Sgo1 by CRISPR/Cas9-mediated genome editing ([@bib45]). We previously showed that, in this cell line, Aurora B is less concentrated at the centromeres and displays diffuse signals along the length of chromosomes compared with control HeLa cells ([@bib45]). Importantly, 5-ITu treatment significantly increased Knl1-pRVSF ([Fig. 8, A and B](#fig8){ref-type="fig"}) and Knl1-pMELT ([Fig. 8, C and D](#fig8){ref-type="fig"}) at metaphase kinetochores in control HeLa cells but not in Sgo1-K492A cells. Similar results were obtained for the localization of Bub1 and Bub3 at metaphase kinetochores ([Fig. S5, C--G](#figS5){ref-type="fig"}). Consistently, time-lapse live imaging demonstrated that 5-ITu delayed the metaphase--anaphase transition in control HeLa cells, but not in Sgo1-K492A cells ([Fig. 8, E--G](#fig8){ref-type="fig"}). These results indicate that H2ApT120-bound Sgo1 is responsible for delayed Knl1 dephosphorylation and SAC silencing in cells lacking the H3pT3--Survivin interaction.

![**Disrupting the H3pT3--Survivin interaction does not delay metaphase Knl1 dephosphorylation and SAC silencing in cells lacking H2ApT120-bound Sgo1.** **(A--D)** DMSO or 5-ITu was added to HeLa or the Sgo1-K492A cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (A and C). The relative intensities of Knl1-pRVSF (B) and Knl1-pMELT (D), representing the normalized ratios of Knl1-pRVSF/ACA and Knl1-pMELT/ACA, were determined in 60 cells from three independent experiments (20 cells per experiment). **(E and F)** DMSO or 0.6 µM 5-ITu was added to HeLa or the Sgo1-K492A cells stably expressing H2B-GFP at 7 h after release from STB, and then mitosis progression was analyzed in ≥67 cells (E). Selected frames of the videos are shown (F). **(G)** DMSO or 0.3 µM 5-ITu was added to HeLa or the Sgo1-K492A cells, and then mitosis progression was analyzed as in E. The means and ranges of mitotic duration were determined in \>74 cells for each condition from two independent experiments. Means and SDs are shown (B, D, E, and G; unpaired *t* test). Time stated in h:min. N.S., not significant. Scale bars, 10 µm. See also [Fig. S5](#figS5){ref-type="fig"}.](JCB_201907092_Fig8){#fig8}

Disrupting H3pT3--Survivin and H2ApT120--Sgo1 interactions additively reduces Aurora B--mediated phosphorylation of Hec1 at prometaphase kinetochores {#s11}
-----------------------------------------------------------------------------------------------------------------------------------------------------

Aurora B phosphorylates the N-terminal segment of Hec1 in early mitosis, which is important for the correction of erroneous KT-MT attachments. We next examined whether loss of centromeric Aurora B affects Hec1 phosphorylation, using the antibody specific for Hec1 Ser-44 phosphorylation (Hec1-pS44; [@bib19], [@bib20]). In line with the observation that 5-ITu treatment did not affect the kinetochore localization of Hec1 in human cells ([@bib17]), Hec1 localized normally to kinetochores in Survivin mutant cells ([Fig. 9, A and B](#fig9){ref-type="fig"}). Compared with control cells, Hec1-pS44 at prometaphase kinetochores was reduced by 14.6--18.1% in Survivin mutant cells ([Fig. 9, A and C](#fig9){ref-type="fig"}) and 5-ITu--treated HeLa cells ([Fig. 9, D and E](#fig9){ref-type="fig"}). Moreover, Hec1-pS44 was nearly undetectable at metaphase kinetochores in Survivin mutant cells ([Fig. 9 A](#fig9){ref-type="fig"}) and 5-ITu--treated HeLa cells ([Fig. 9 D](#fig9){ref-type="fig"}), as in control cells. Consistently, the cold-stable tubulin of metaphase spindle was not detectably altered in Survivin mutant cells ([Fig. 9 F](#fig9){ref-type="fig"}) and 5-ITu--treated cells ([Fig. 9 G](#fig9){ref-type="fig"}), indicative of proper stabilization of KT-MT attachment.

![**Disrupting H3pT3--Survivin and H2ApT120--Sgo1 interactions additively reduces Aurora B--mediated phosphorylation of Hec1 at prometaphase kinetochores.** **(A--C)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (A). The relative intensities of Hec1 (B) and Hec1-pS44 (C), representing the normalized ratios of Hec1/ACA and Hec1-pS44/ACA, were determined in 60 cells from three independent experiments (20 cells per experiment). **(D and E)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for immunostaining. Example images are shown (D). The relative intensity of Hec1-pS44 was determined as in C (E). **(F)** MG132 was added to the indicated Survivin stable cell lines 10 h after release from STB. Cells were treated with cold medium 12 h after release and then fixed and immunostained. The collected images were deconvolved and analyzed. **(G)** DMSO or 5-ITu was added to HeLa cells 9 h after release from STB, and then MG132 was added 10 h after release. Cells were treated with cold medium 12 h after release and then fixed and immunostained. The collected images were deconvolved and analyzed. **(H and I)** The indicated Survivin stable cell lines were released from STB for 12 h and then immunostained. Example images are shown (H). The relative intensity of Hec1-pS44 was determined as in C (I). Means and SDs are shown (B, C, E, and I; unpaired *t* test). N.S., not significant. Scale bars, 10 µm.](JCB_201907092_Fig9){#fig9}

We further found that, compared to DMSO treatment, BAY 1816032 treatment reduced Hec1-pS44 at prometaphase kinetochores by 13.3% and 18.5% in cells expressing Survivin-WT-Myc and Survivin-H80A-Myc, respectively ([Fig. 9, H and I](#fig9){ref-type="fig"}), implying the contribution of the H2ApT120-dependent pool of Aurora B to Hec1-pS44 at prometaphase kinetochores. Moreover, compared with that in Survivin-WT-Myc cells treated with DMSO, the level of Hec1-pS44 in Survivin-H80A-Myc cells treated with BAY 1816032 was reduced by 36.7%. Taken together, these results indicate that H3pT3- and H2ApT120-dependent localization of Aurora B additively and substantially contributes to Hec1-pS44, but not Knl1-pRVSF, at prometaphase kinetochores.

Disrupting H3pT3--Survivin interaction increases chromosome missegregation in the absence of H2ApT120--Sgo1 interaction {#s12}
-----------------------------------------------------------------------------------------------------------------------

To assess the relative functional contribution of H3pT3- and H2ApT120-dependent pathways of Aurora B recruitment, we examined chromosome segregation in cells lacking one or both pathways. Cells expressing WT or the mutant forms of Survivin-Myc had similarly low levels of anaphases with lagging chromosomes ([Fig. 10, A and B](#fig10){ref-type="fig"}). Interestingly, upon treatment with BAY 1816032, the frequency of anaphase lagging chromosomes was significantly higher in cells expressing the Survivin mutants than in Survivin-WT-Myc cells. Consistently, while treatment with 5-ITu alone barely affected chromosome segregation in HeLa cells, it strongly increased the frequency of anaphase lagging chromosomes in the presence of BAY 1816032 ([Fig. 10, C and D](#fig10){ref-type="fig"}). Similar results were obtained in the nontransformed retinal pigment epithelial-1 cells treated with 5-ITu and BAY 1816032 ([Fig. 10, E and F](#fig10){ref-type="fig"}). Therefore, the H3pT3--Survivin interaction becomes essential for the fidelity of chromosome segregation in the absence of Bub1 kinase activity.

![**Disrupting H3pT3--Survivin interaction increases chromosome missegregation in the absence of H2ApT120-Sgo1 interaction.** **(A and B)** DMSO or BAY 1816032 was added to HeLa cells or the indicated Survivin stable cell lines 9 h after release from STB. Cells were then fixed 12 h after release for DNA staining. The percentage of cells with lagging chromosomes was determined in \>300 anaphase cells from three independent experiments (A). Example images are shown (B). **(C and D)** DMSO or the indicated inhibitors were added to HeLa cells 9 h after release from STB. Cells were then fixed 12 h after release for DNA staining. The percentage of cells with lagging chromosomes was determined in \>300 anaphase cells from three independent experiments (C). Example images are shown (D). **(E and F)** DMSO or the indicated inhibitors were added to retinal pigment epithelial-1 cells 9 h after release from STB. Cells were then fixed 12 h after release for DNA staining. The percentage of cells with lagging chromosomes was determined in \>300 anaphase cells from three independent experiments (E). Example images are shown (F). **(G and H)** DMSO or 5-ITu was added to HeLa or the Sgo1-K492A cells at 9 h after release from STB. Cells were then fixed at 12 h after release for DNA staining. Means and ranges for the percentage of anaphase lagging chromosomes were determined in \>200 anaphase cells from two independent experiments (G). Example images are shown (H). **(I)** DMSO or BAY 1816032 were added to the indicated Survivin stable cell lines 9 h after release from STB, and then MG132 was added 10 h after release. Cells were treated with cold medium 12 h after release and then fixed and immunostained. The collected images were deconvolved and analyzed. **(J)** Model for the role of H3pT3- and H2ApT120-dependent localization of Aurora B at centromeres in regulating kinetochore function and chromosome segregation. Means and SDs are shown (A, C, E, and G; unpaired *t* test). N.S., not significant. Arrows point to the lagging chromosome (B, D, F, and H) or the merotelic KT-MT attachment (I). Scale bars, 10 µm.](JCB_201907092_Fig10){#fig10}

We further assessed the effect of 5-ITu on chromosome segregation in Sgo1-K492A cells, which lack H2ApT120-dependent localization of Sgo1 and CPC at centromeres ([@bib44]). Consistent with the effect of BAY 1816032 on chromosome segregation in HeLa cells ([Fig. 10, A--D](#fig10){ref-type="fig"}), the rate of anaphase lagging chromosomes was slightly higher in Sgo1-K492A cells than in control HeLa cells ([Fig. 10, G and H](#fig10){ref-type="fig"}). Importantly, 5-ITu treatment obviously increased the frequency of anaphase lagging chromosomes in Sgo1-K492A cells but not in control HeLa cells, indicating that the H2ApT120--Sgo1 interaction is required to suppress chromosome missegregation in cells lacking H3pT3.

Anaphase lagging chromosomes usually result from merotelic kinetochore attachment in which a single kinetochore is simultaneously attached to microtubules from both spindle poles. Indeed, we found that 32.3% of Survivin-H80A-Myc cells treated with BAY 1816032 had at least one merotelically attached kinetochore, which was an approximately threefold increase over control Survivin-WT-Myc cells with mock treatment ([Fig. 10 I](#fig10){ref-type="fig"}). Taken together, these results indicate that H2ApT120-dependent localization of Aurora B is required to prevent merotelic attachment and chromosome missegregation in the absence of the H3pT3-dependent pool of Aurora B.

Discussion {#s13}
==========

In this study, we investigated the role of centromere-localized Aurora B in mitotic human cells. By mutating key residues in the H3pT3-binding BIR domain of Survivin, which disrupts the H3pT3-dependent localization of Aurora B at inner centromeres but retains proper centromeric cohesion ([@bib44]), we found a pool of Aurora B at the KT-proximal centromere in prometaphase and metaphase cells. We confirmed this finding by using the Haspin kinase inhibitor 5-ITu, similar to previous observations for Borealin in 5-ITu--treated cells ([@bib4]). This pool of Aurora B persists in the presence of the spindle poison nocodazole, ruling out the involvement of CPC binding to microtubules ([@bib2]; [@bib24]; [@bib63]; [@bib71]; [@bib80]). We presented several lines of evidence indicating that H2ApT120-bound Sgo1 provides the docking site for Aurora B at the KT-proximal centromere. First, H2ApT120 and Sgo1 are able to recruit Aurora B even in the absence of H3pT3. Second, disrupting the H3pT3--Survivin interaction impedes the decline in H2ApT120 and Sgo1 during metaphase, which is accompanied by accumulation of Aurora B at the KT-proximal centromere. Third, Aurora B colocalizes with H2ApT120 at the KT-proximal centromere when the H3pT3--Survivin interaction is lost. Fourth, erasing H2ApT120 by inhibiting Bub1 kinase activity, or disrupting the H2ApT120-Sgo1 interaction, removes Aurora B from the KT-proximal centromere.

Aurora B phosphorylates multiple targets within the KMN network in early mitosis, subsequent dephosphorylation of which during metaphase is important for the stabilization of KT-MT attachments and silencing of the SAC. We found that metaphase dephosphorylation of Aurora B target sites in Hec1 and Knl1 responds differentially to the loss of the centromeric CPC. We used phospho-specific antibodies that probe Aurora B activity at kinetochores at a known distance from CENP-A at the inner edge of kinetochores (Knl1-pS60 ∼80 nm and Hec1-pS44 ∼110 nm at metaphase; [@bib76]; [@bib79]). We observed that, upon loss of the H3pT3-dependent pool of Aurora B at inner centromeres, Hec1-S44 is normally dephosphorylated in metaphase, whereas dephosphorylation of the Knl1-RVSF motif is significantly delayed due to the maintenance of a H2ApT120-dependent pool of Aurora B at metaphase KT-proximal centromeres. The correlation between metaphase dephosphorylation of Hec1 and Knl1 with their relative distance to the inner centromere lends support for the spatial separation model for kinetochore substrate phosphorylation by centromeric Aurora B ([@bib41]; [@bib46]; [@bib66]; [@bib79]). However, this model cannot explain our finding that H3pT3- and H2ApT120-dependent pools of Aurora B at centromeres additively contribute to Hec1-pS44 but are not required for Knl1-pRVSF at prometaphase kinetochores. Therefore, the Knl1-RVSF motif is phosphorylated by another pool of Aurora B that may or may not reside at the kinetochore ([@bib7]; [@bib19]).

We further found that, in cells lacking H3pT3-dependent Aurora B at inner centromeres, the enhanced phosphorylation of Knl1-RVSF/SSILK motifs at metaphase kinetochores is accompanied by defects in dephosphorylating Knl1-MELT and releasing Bubs, eventually leading to a delay in SAC silencing. Our data indicate that inhibition of PP1γ recruitment to Knl1 due to metaphase phosphorylation of the PP1-binding motif of Knl1 by H2ApT120/Sgo1-associated Aurora B is the root cause for SAC silencing delay, though we cannot fully rule out the possibility that subtle defects in KT-MT attachment may also affect SAC. Thus, regardless of whether H3pT3 and H2ApT120 may directly compete for the recruitment of the CPC to centromeres, upon loss of the H3pT3-dependent pool of Aurora B at the inner centromere, the Bub1-H2ApT120-Sgo1-CPC pathway can form a positive feedback circuit that causes the accumulation of Aurora B at metaphase kinetochores, which then feeds back to phosphorylate Knl1-RVSF and sustain Bub1 at metaphase kinetochores. These results not only represent the evidence for an indirect role of Bub1 kinase activity in inhibiting SAC silencing under certain circumstances, such as when the H3pT3-dependent pool of Aurora B at inner centromeres is lost, but also lend support for the role of PP1γ ([@bib58]), as well as the B56 family of PP2A ([@bib22]), in SAC silencing. Our data may also explain the metaphase delay in the cohesin releaser Wapl-depleted HeLa cells expressing centromere-targeting domain of CENP-B--fused INCENP ([@bib32]). We conclude that timely silencing of the SAC requires strict confinement of Aurora B to the inner centromere by H3pT3, which allows spatial separation of Knl1 from centromeric Aurora B during metaphase. We reason that cells lacking H3pT3--Survivin interaction are capable of exiting mitosis in the end because the sustained kinetochore tension eventually pulls Knl1 out of the influence of Aurora B.

Merotelic KT-MT attachment, which allows chromosome alignment on the metaphase spindle and can satisfy the SAC ([@bib27]), represents a major cause of chromosome missegregation during mitosis and is the primary mechanism of chromosomal instability in cancer cells ([@bib68]). Our data indicate that accumulation of a sufficient amount of active Aurora B at the centromere by H3pT3 and H2ApT120 makes the system robust enough to correct merotelic KT-MT attachment. Consistently, the CPC mutant incapable of localizing to centromeres is unable to correct attachment errors in *Xenopus laevis* egg extracts ([@bib29]). In contrast, deletion of the N-terminal centromere-targeting domain of the INCENP homologue Sli15 (Sli15-ΔNT) did not cause severe defects in chromosome segregation in budding yeast ([@bib8]), which could be because merotelic attachment is not possible in this organism where there is only one microtubule-binding site on each kinetochore ([@bib5]). Nevertheless, metaphase chromosome alignment eventually occurs in human cells lacking both H3pT3- and H2ApT120-dependent localization of Aurora B to centromeres, though with diminished efficiency. This is in line with the observation that ∼60% residual Hec1-pS44 signal is present at prometaphase kinetochores in the absence of centromeric Aurora B. Consistently, partial inhibition of Aurora B kinase activity by a small-molecule inhibitor increased the frequency of merotelic KT-MT attachment in mammalian cells but had little effect on metaphase chromosome alignment ([@bib14]). Future studies are required to identify the pool of Aurora B that supports metaphase chromosome alignment in cells lacking the H3pT3-dependent and H2ApT120-dependent pools of Aurora B at centromeres.

In summary, we demonstrate that the H2ApT120-dependent pool of Aurora B at the KT-proximal centromere can compensate for the loss of an H3pT3-dependent pool of Aurora B at inner centromeres to correct erroneous KT-MT attachments. We suggest that this is achieved not only through maintaining a sufficient amount of residual Aurora B at the KT-proximal centromere but also by delaying the metaphase--anaphase transition, thereby enabling efficient phosphorylation of outer kinetochores that drive error correction ([Fig. 10 J](#fig10){ref-type="fig"}). Similarly, two recent studies reported the existence of a pool of Aurora B/Ipl1 at the inner kinetochore that can support chromosome bi-orientation in the Sli15-ΔNT mutant yeast cells ([@bib25]; [@bib26]). Taken together, our results reveal the role of centromeric Aurora B in ensuring the fidelity of chromosome segregation in human cells and suggest an alternative for the model of tension sensing by spatial separation of centromeric Aurora B from kinetochore substrates ([@bib41]; [@bib46]; [@bib66]).

Materials and methods {#s14}
=====================

Cell culture, plasmids, siRNA, transfection, and drug treatments {#s15}
----------------------------------------------------------------

All cells were cultured in DMEM supplemented with 1% penicillin/streptomycin and 10% FBS (Gibco) and maintained at 37°C with 5% CO~2~. U2OS-LacO cells from Dr. David Spector (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) were maintained in the presence of 100 µg/ml hygromycin (Sigma-Aldrich). HeLa cells stably expressing pEF6-Survivin-Myc-6xHis in which endogenous Survivin was knocked out by CRISPR/Cas9 were maintained in 2 µg/ml blasticidin (Sigma-Aldrich). These Survivin stable cell lines were further cotransfected with pBos-H2B-GFP (Clontech) and pTRE2 (Clontech) in a 9:1 ratio, and then the clonal cell lines were selected with 1 µg/ml puromycin (Thermo Fisher Scientific). Regular HeLa cells and HeLa-derived Sgo1-K492A cells stably expressing H2B-GFP were maintained in 2 µg/ml blasticidin.

To make the EGFP-LacI fusion constructs, the PCR fragments of Bub1, Haspin, or Sgo1 were inserted into the BsiWI/BamHI sites of pSV2-EGFP-LacI. EGFP-LacI-Bub1-K (WT or D946N) contained residues 630--1,085 of Bub1 including the kinase domain. EGFP-LacI-Haspin (WT or K511A) contained full-length Haspin. EGFP-LacI-Haspin-K (WT or K511A) contained the kinase domain of Haspin (residues 471--798). EGFP-LacI-Sgo1 contained full-length Sgo1. Sgo1-Myc-LacI was constructed based on the Myc-LacI-Bub1 plasmid, which was kindly provided by Dr. Sabine Elowe (Université Laval, Québec, Canada; [@bib1]). All point mutations were introduced with the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies). All plasmids were sequenced to verify desired mutations and absence of unintended mutations.

The control siRNA ([@bib77]) and Sgo1 siRNA (5′-CAGUAGAACCUGCUCAGAAdTdT-3′; [@bib86]) were ordered from RiboBio. Plasmid and siRNA transfections were done with Fugene 6 (Promega) and Lipofectamine RNAiMAX (Invitrogen), respectively. Cells were arrested in S phase or at the G1/S boundary by single or double thymidine (2 mM, Calbiochem) treatment, respectively. Cells were arrested in prometaphase-like mitosis with 0.33 or 3.3 µM nocodazole (Selleckchem) or were arrested in metaphase with MG132 (10 µM, Sigma-Aldrich). The small-molecule inhibitors were 5-ITu (0.3--3 µM, Tocris) and BAY 1816032 (3--5 µM, Chemietech). Mitotic cells were collected by selective detachment with shake-off.

Antibodies and immunoblotting {#s16}
-----------------------------

Rabbit polyclonal antibodies used were to Cyclin B1 (clone D5C10, Sigma-Aldrich), GAPDH (14C10, Cell Signaling Technology), GFP (A11122, Invitrogen), H2ApT120 (Active Motif), Survivin (NB500-201, Novus Biologicals), INCENP (P240, Sigma-Aldrich), H3pT3 from Dr. Jonathan Higgins (Newcastle University, Newcastle upon Tyne, UK), Hec1-pS44 from Dr. Jennifer DeLuca (Colorado State University, Fort Collins, CO), Knl1-pS24 and Knl1-pS60 from Dr. Iain Cheeseman (Whitehead Institute for Biomedical Research, Cambridge, MA), and Knl1-pT180 from Dr. Geert Kops (Oncode Institute, Hubrecht Institute-KNAW, Utrecht, Netherlands). Rabbit anti-Bub1 and anti-Knl1 polyclonal antibodies were produced by immunization with the synthetic peptides NYGLPQPKNKPTGAR and MDGVSSEANEENDNIERPVRRR, respectively. Mouse monoclonal antibodies used were to Aurora B (AIM-1; BD Biosciences), Bub3 (Clone 31, BD Transduction Laboratories), BubR1 from Dr. Jakob Nilsson (University of Copenhagen, Copenhagen, Denmark), H3pT3 (16B2) from Dr. Hiroshi Kimura (Tokyo Institute of Technology, Yokohama, Japan), Hec1 (GTX70268, GeneTex), α-Tubulin (T-6047, Sigma-Aldrich), and Sgo1 (3C11, Abnova). Guinea pig polyclonal antibodies against CENP-C were from MBL (PD030). The anti-human centromere autoantibody (ACA) was from Immunovision. Secondary antibodies for immunoblotting were goat anti-rabbit or horse anti-mouse IgG-HRP (Sigma-Aldrich). Secondary antibodies for immunostaining were donkey anti-rabbit IgG-Alexa Fluor 488 or Cy3 (Jackson ImmunoResearch); anti-mouse IgG-Alexa Fluor 488 or 546 (Invitrogen) or CY5 (Jackson ImmunoResearch); anti-human IgG-Alexa Fluor 647 (Jackson ImmunoResearch); and goat anti-guinea pig IgG-Alexa Fluor 647 (Invitrogen). SDS-PAGE and immunoblotting were performed using standard procedures using whole-cell lysates prepared in standard SDS sample buffer.

Chromosome spreads {#s17}
------------------

Survivin stable cell lines ([Fig. 3 A](#fig3){ref-type="fig"}) and HeLa cells ([Fig. 3 B](#fig3){ref-type="fig"}) were treated with MG132 (10 µM) 10 h after release from single thymidine block (STB), and then collected 15 h after release to prepare chromosome spreads. HeLa cells were treated with nocodazole (0.33 µM for [Fig. 3 C](#fig3){ref-type="fig"}; 3.3 µM for [Fig. 3 D](#fig3){ref-type="fig"}) 9 h after release from STB and then collected 12 h after release. To produce chromosome spreads, mitotic cells were obtained by selective detachment and then incubated in hypotonic buffer (75 mM KCl) at room temperature for 8--10 min. After attachment to glass coverslips by Cytospin at 1,500 rpm for 5 min, chromosome spreads were fixed with 2% PFA/PBS for 10 min, extracted with 0.5% Triton X-100/PBS for another 10 min, and then subjected to blocking with 3% BSA/PBS and subsequent immunostaining with primary antibodies for 2 h.

Fluorescence microscopy {#s18}
-----------------------

Asynchronous U2OS-LacO cells were fixed with 2% PFA in PBS for 10 min and then extracted with 0.5% Triton X-100 for 5 min. For HeLa or HeLa-derived stable cell lines grown on coverslips, to stain Sgo1, H2ApT120, BubR1, Hec1, Hec1-pS44, and Knl1, cells were fixed with 2% PFA/PBS for 10 min and then extracted by 0.5% Triton X-100/PBS for 10 min; to stain Knl1-pS24, Knl1-pS60, and Knl1-pT180, cells were preextracted with 0.5% Triton X-100 in PHEM (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM MgCl~2~, pH 6.9) for 5 min and then fixed with 4% PFA in PHEM for 20 min. Fixed cells were stained with primary antibodies for 1--2 h and secondary antibodies for 1 h, all with 3% BSA in PBS with 0.1--0.5% Triton X-100 and at room temperature. DNA was stained for 10 min with DAPI. Fluorescence microscopy was performed at room temperature using a Nikon ECLIPSE Ni microscope with a Plan Apo Fluor 60× oil (NA 1.4) objective lens and a Clara charge-coupled devide (Andor Technology).

For K-fiber staining, cells were incubated with cold medium for 10 min. Then, after cells were extracted with 0.2% Triton X-100/PHEM for 1 min, an equal volume of 4% PFA/PHEM was added. After 5 min, the mixture was removed, and 4% PFA/PBS was added for 5 min. After blocking with 3% BSA/PBS, cells were stained with α-Tubulin antibody and ACA 1:1,000. Images were acquired through the entire cell as z stacks at 0.2-µm intervals on a deconvolution system (DeltaVision Elite Applied Precision/GE Healthcare) with a 100×/1.40-NA UPlanSApo objective (Olympus) using SoftWorx software (Applied Precision/GE Healthcare) and then deconvolved, and maximum-intensity projections were made using SoftWoRx.

Quantification of fluorescent intensity was performed with ImageJ (National Institutes of Health) using images obtained at identical illumination settings. Briefly, to quantify the relative intensity at the centromere/kinetochore, the average pixel intensity of H2ApT120, Sgo1, Bub1, Bub3, BubR1, Knl1, Knl1-pMELT, Knl1-pRVSF, Knl1-pSSILK, Hec1, Hec1-pS44, or ACA staining at centromeres/kinetochores, defined as a circular region encompassing at least three centromere pairs, was determined using ImageJ. After background correction, the ratio of centromere/kinetochore immunostaining intensity of these proteins versus that of ACA was calculated for each circular region. To quantify the means and SDs for the relative intensity of proteins of interest at centromeres/kinetochores from individual experiments, a total of 200 circular regions from 20 cells (10 nonoverlapping circular regions per cell) were plotted ([Fig. 2, B, D, G, and I](#fig2){ref-type="fig"}; [Fig. S2, B, D, F, and H](#figS1){ref-type="fig"}; [Fig. S3 F](#figS3){ref-type="fig"}; [Fig. S4, B, D, and E](#figS4){ref-type="fig"}; and [Fig. S5, D--G](#figS5){ref-type="fig"}). The means and SDs for the relative intensity of proteins of interest at centromeres/kinetochores from three independent experiments were quantified from 60 cells (20 cells per experiment), in which the average intensity of a single cell was determined by the means of 10 circular regions that contained \>300 centromere pairs in total ([Fig. 2, C, E, H, and J](#fig2){ref-type="fig"}; [Fig. 5, B, D, F, G, I, and J](#fig5){ref-type="fig"}; [Fig. 6, B, D, F, and G](#fig6){ref-type="fig"}; [Fig. 7, B, D, F, and G](#fig7){ref-type="fig"}; [Fig. 8, B and D](#fig8){ref-type="fig"}; [Fig. 9, B, C, E, and I](#fig9){ref-type="fig"}; and [Fig. S3, B and D](#figS3){ref-type="fig"}).

To quantify the relative enrichment of proteins of interest at the LacO transgene array in U2OS-LacO cells ([Fig. 1, B, C, E, and G](#fig1){ref-type="fig"}), the average pixel intensity of H3pT3, H2ApT120, Aurora B, and Sgo1, within circles encompassing the EGFP-LacI fusion protein fluorescent signal at LacO transgene array and in the nearby nucleus, was determined. After background correction, the ratio of average immunostaining intensity at LacO repeats versus that in the nuclei was calculated. ImageJ was also used for the plot profiles of Aurora B, H2ApT120, and CENP-C at centromeres/kinetochores on chromosome spreads ([Fig. 3, C and D](#fig3){ref-type="fig"}). The intensities of Aurora B, H2ApT120, and CENP-C at centromeres/kinetochores were quantified along the lines of paired CENP-C dots. 10 sister centromeres were quantified and plotted for each cell. While the x axis represents the distance to the middle position of the paired CENP-C dots, the y axis represents the relative pixel intensities of Aurora B, H2ApT120, and CENP-C at the lines of CENP-C dots.

Time-lapse live cell imaging {#s19}
----------------------------

Time-lapse live cell imaging was performed with the GE DV Elite Applied Precision DeltaVision system (GE Healthcare) equipped with Olympus oil objectives of 60× (NA 1.42) Plan Apo N or 40× (NA 1.35) UApo/340 and an API Custom Scientific complementary metal-oxide semiconductor camera, and Resolve3D softWoRx imaging software. Cells expressing H2B-GFP were plated in four-chamber glass-bottomed 35-mm dishes (Cellvis) coated with poly-[d]{.smallcaps}-lysine and filmed in a climate-controlled and humidified environment (37°C and 5% CO~2~). Images were captured every 2 min. The acquired images were processed using Adobe Photoshop and Adobe Illustrator.

Statistical analysis {#s20}
--------------------

Statistical analyses were performed with a two-tailed unpaired Student's *t* test in GraphPad Prism 6. A P value of \<0.05 was considered significant.

Online supplemental material {#s21}
----------------------------

[Fig. S1](#figS1){ref-type="fig"} shows the immunoblots demonstrating stable replacement of endogenous Survivin by exogenously expressed Survivin-Myc proteins and time-lapse live imaging of mitosis progression in HeLa or Survivin-Myc-expressing cells treated with DMSO, 5-ITu, and/or BAY 1816032, supporting [Fig. 4](#fig4){ref-type="fig"}. [Fig. S2](#figS2){ref-type="fig"} shows that loss of the H3pT3--Survivin interaction hampers the removal of Bub3, Bub1, and BubR1 from metaphase kinetochores, supporting [Fig. 5](#fig5){ref-type="fig"}. [Fig. S3](#figS3){ref-type="fig"} shows that loss of the H3pT3--Survivin interaction does not affect the kinetochore localization of Knl1 but hinders dephosphorylation of the Knl1-MELT motif at metaphase kinetochores, supporting [Fig. 6](#fig6){ref-type="fig"}. [Fig. S4](#figS4){ref-type="fig"} shows that loss of the H3pT3--Survivin interaction impedes the dephosphorylation of the RVSF and SSILK motifs of Knl1 at metaphase kinetochores, supporting [Fig. 7](#fig7){ref-type="fig"}. [Fig. S5](#figS5){ref-type="fig"} shows that tethering Sgo1 to the LacO array can recruit INCENP and Aurora B, and that loss of the H3pT3--Survivin interaction does not hamper the removal of Bub3 and Bub1 from metaphase kinetochores in cells expressing the H2ApT120 binding--deficient Sgo1-K492A mutant, supporting [Fig. 8](#fig8){ref-type="fig"}. [Videos 1](#video1){ref-type="fig"}, [2](#video2){ref-type="fig"}, and [3](#video3){ref-type="fig"} are related to [Fig. 4 A](#fig4){ref-type="fig"} and show time-lapse epifluorescence microscopy of mitosis progression in HeLa cells expressing Survivin-WT-Myc and H2B-GFP ([Video 1](#video1){ref-type="fig"}), Survivin-K62A-Myc and H2B-GFP ([Video 2](#video2){ref-type="fig"}), and Survivin-H80A-Myc and H2B-GFP ([Video 3](#video3){ref-type="fig"}). [Videos 4](#video4){ref-type="fig"}, [5](#video5){ref-type="fig"}, and [6](#video6){ref-type="fig"} are related to [Fig. 4 C](#fig4){ref-type="fig"} and show time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP--expressing HeLa cells treated with DMSO ([Video 4](#video4){ref-type="fig"}) and H2B-GFP--expressing HeLa cells treated with 0.3 µM 5-ITu ([Video 5](#video5){ref-type="fig"}) or 0.6 µM 5-ITu ([Video 6](#video6){ref-type="fig"}). [Videos 7](#video7){ref-type="fig"} and [8](#video8){ref-type="fig"} are related to [Fig. 4 D](#fig4){ref-type="fig"} and show time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP--expressing HeLa cells released from MG132 into DMSO ([Video 7](#video7){ref-type="fig"}) or 0.6 µM 5-ITu ([Video 8](#video8){ref-type="fig"}). [Videos 9](#video9){ref-type="fig"} and [10](#video10){ref-type="fig"} are related to [Fig. S1](#figS1){ref-type="fig"} H and show time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP--expressing HeLa cells treated with DMSO ([Video 9](#video9){ref-type="fig"}) or 4 µM BAY 1816032 ([Video 10](#video10){ref-type="fig"}).
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###### 

**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP--expressing HeLa cells treated with DMSO.** Related to Fig. S1 H. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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###### 

**Time-lapse epifluorescence microscopy of mitosis progression in H2B-GFP--expressing HeLa cells treated with 4 µM BAY 1816032.** Related to Fig. S1 H. Images were captured once every 2 min. Video is displayed at 5 frames/s. Time stamps indicate h:min:s.
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